PSMA PET/CT in Renal Cell Carcinoma: An Overview of Current Literature

被引：25
作者：
Muselaers, Stijn [1 ]
Erdem, Selcuk [2 ]
Bertolo, Riccardo [3 ]
Ingels, Alexandre [4 ]
Kara, Onder [5 ]
Pavan, Nicola [6 ]
Roussel, Eduard [7 ]
Pecoraro, Angela [8 ]
Marchioni, Michele [9 ]
Carbonara, Umberto [10 ]
Marandino, Laura [11 ]
Amparore, Daniele [8 ]
Campi, Riccardo [12 ]
机构：
[1] Radboud Univ Nijmegen, Dept Urol, Med Ctr, NL-6525 GA Nijmegen, Netherlands
[2] Istanbul Univ, Fac Med, Dept Urol, Div Urol Oncol, TR-34452 Istanbul, Turkey
[3] San Carlo Di Nancy Hosp, Dept Urol, I-00165 Rome, Italy
[4] Univ Hosp Henri Mondor, AP HP, Dept Urol, F-94000 Creteil, France
[5] Kocaeli Univ, Sch Med, Dept Urol, TR-41001 Izmit, Turkey
[6] Univ Trieste, Dept Med Surg & Hlth Sci, Urol Clin, I-34127 Trieste, Italy
[7] Univ Hosp Leuven, Dept Urol, B-3000 Leuven, Belgium
[8] Univ Turin, San Luigi Gonzaga Hosp, Dept Urol, I-10124 Turin, Italy
[9] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, I-66100 Chieti, Italy
[10] Univ Bari, Dept Emergency & Organ Transplantat Urol Androl &, I-70121 Bari, Italy
[11] IRCCS Osped San Raffaele, Dept Med Oncol, I-20132 Milan, Italy
[12] Univ Florence, Careggi Hosp, Unit Urol Robot Surg & Renal Transplantat, I-50121 Florence, Italy
来源：
JOURNAL OF CLINICAL MEDICINE | 2022年 / 11卷 / 07期
关键词：
PSMA PET; CT; renal cell carcinoma; kidney cancer; imaging; MEMBRANE ANTIGEN; F-18-DCFPYL PET/CT; F-18-FDG PET/CT; TOMOGRAPHY; EXPRESSION; NEOVASCULATURE; RECURRENCE; TRACER; TUMORS;
D O I：
10.3390/jcm11071829
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Although the vast majority of prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging occurs in the field of prostate cancer, PSMA is also highly expressed on the cell surface of the microvasculature of several other solid tumors, including renal cell carcinoma (RCC). This makes it a potentially interesting imaging target for the staging and monitoring of RCC. The objective of this review is to provide an overview of the current evidence regarding the use of PSMA PET/Computed Tomography in RCC patients.
引用
收藏
页数：11
相关论文
共 38 条
[1]   Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms [J].
Baccala, Angelo ;
Sercia, Linda ;
Li, Jianbo ;
Heston, Warren ;
Zhou, Ming .
UROLOGY, 2007, 70 (02) :385-390
[2]   Epidemiology of Renal Cell Carcinoma [J].
Capitanio, Umberto ;
Bensalah, Karim ;
Bex, Axel ;
Boorjian, Stephen A. ;
Bray, Freddie ;
Coleman, Jonathan ;
Gore, John L. ;
Sun, Maxine ;
Wood, Christopher ;
Russo, Paul .
EUROPEAN UROLOGY, 2019, 75 (01) :74-84
[3]   Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen [J].
Chang, SS ;
Reuter, VE ;
Heston, WDW ;
Gaudin, PB .
UROLOGY, 2001, 57 (04) :801-805
[4]   2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer [J].
Chen, Ying ;
Pullambhatla, Mrudula ;
Foss, Catherine A. ;
Byun, Youngjoo ;
Nimmagadda, Sridhar ;
Senthamizhchelvan, Srinivasan ;
Sgouros, George ;
Mease, Ronnie C. ;
Pomper, Martin G. .
CLINICAL CANCER RESEARCH, 2011, 17 (24) :7645-7653
[5]   Detection Rate of Prostate Specific Membrane Antigen Tracers for Positron Emission Tomography/Computerized Tomography in Prostate Cancer Biochemical Recurrence: A Systematic Review and Network Meta-Analysis [J].
Crocerossa, Fabio ;
Marchioni, Michele ;
Novara, Giacomo ;
Carbonara, Umberto ;
Ferro, Matteo ;
Russo, Giorgio I. ;
Porpiglia, Francesco ;
Di Nicola, Marta ;
Damiano, Rocco ;
Autorino, Riccardo ;
Cantiello, Francesco .
JOURNAL OF UROLOGY, 2021, 205 (02) :356-369
[6]   68Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma [J].
Demirci, Emre ;
Ocak, Meltem ;
Kabasakal, Levent ;
Decristoforo, Clemens ;
Talat, Zubeyir ;
Halac, Metin ;
Kanmaz, Bedii .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (07) :1461-1462
[7]   Comparison of [18F]DCFPyL and [68Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer [J].
Dietlein, Markus ;
Kobe, Carsten ;
Kuhnert, Georg ;
Stockter, Simone ;
Fischer, Thomas ;
Schomaecker, Klaus ;
Schmidt, Matthias ;
Dietlein, Felix ;
Zlatopolskiy, Boris D. ;
Krapf, Philipp ;
Richarz, Raphael ;
Neubauer, Stephan ;
Drzezga, Alexander ;
Neumaier, Bernd .
MOLECULAR IMAGING AND BIOLOGY, 2015, 17 (04) :575-584
[8]   Positron Emission Tomography/Computed Tomography Identification of Clear Cell Renal Cell Carcinoma: Results From the REDECT Trial [J].
Divgi, Chaitanya R. ;
Uzzo, Robert G. ;
Gatsonis, Constantine ;
Bartz, Roman ;
Treutner, Silke ;
Yu, Jian Qin ;
Chen, David ;
Carrasquillo, Jorge A. ;
Larson, Steven ;
Bevan, Paul ;
Russo, Paul .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (02) :187-194
[9]   Novel Preclinical and Radiopharmaceutical Aspects of [Ga-68]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer [J].
Eder, Matthias ;
Neels, Oliver ;
Mueller, Miriam ;
Bauder-Wust, Ulrike ;
Remde, Yvonne ;
Schaefer, Martin ;
Hennrich, Ute ;
Eisenhut, Michael ;
Afshar-Oromieh, Ali ;
Haberkorn, Uwe ;
Kopka, Klaus .
PHARMACEUTICALS, 2014, 7 (07) :779-796
[10]   Comprehensive evaluation of68Ga-PSMA-11 PET/CT parameters for discriminating pathological characteristics in primary clear-cell renal cell carcinoma [J].
Gao, Jie ;
Xu, Qinfeng ;
Fu, Yao ;
He, Kuiqiang ;
Zhang, Chengwei ;
Zhang, Qing ;
Shi, Jiong ;
Zhao, Xiaozhi ;
Wang, Feng ;
Guo, Hongqian .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (02) :561-569
1234